Sunil Healthcare Limited (BOM:537253)
India
· Delayed Price · Currency is INR 63.00
-4.00 (-5.97%)
At close: Mar 9, 2026
Sunil Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 892.01 | 834.21 | 901.92 | 1,105 | 1,192 | 906.2 | Upgrade
|
| Revenue Growth (YoY) | 6.79% | -7.51% | -18.37% | -7.28% | 31.50% | 29.42% | Upgrade
|
| Cost of Revenue | 359.82 | 379.03 | 486.28 | 501.59 | 522.31 | 452.44 | Upgrade
|
| Gross Profit | 532.19 | 455.18 | 415.64 | 603.32 | 669.33 | 453.76 | Upgrade
|
| Selling, General & Admin | 135.03 | 124.35 | 130.57 | 149.15 | 143.89 | 127.02 | Upgrade
|
| Other Operating Expenses | 241.59 | 211.18 | 242.47 | 289.13 | 315.46 | 245.78 | Upgrade
|
| Operating Expenses | 442.83 | 399.31 | 433.89 | 511.58 | 554.35 | 433.94 | Upgrade
|
| Operating Income | 89.36 | 55.88 | -18.25 | 91.74 | 114.99 | 19.82 | Upgrade
|
| Interest Expense | -52.99 | -57.01 | -47.5 | -33.32 | -25.54 | -44.97 | Upgrade
|
| Interest & Investment Income | 3.28 | 3.28 | 2.55 | 2.11 | 2.16 | 3.18 | Upgrade
|
| Currency Exchange Gain (Loss) | -13.7 | -13.7 | 11.53 | 12.79 | 7.06 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.56 | -6.72 | -9.24 | -5.55 | -9.29 | 5.68 | Upgrade
|
| EBT Excluding Unusual Items | 28.52 | -18.26 | -60.92 | 67.77 | 89.38 | -16.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.05 | 0.63 | 0.22 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.05 | -1.05 | -1.73 | 0.9 | -0.01 | -0.6 | Upgrade
|
| Other Unusual Items | 7.15 | 7.15 | 8.96 | 26.12 | 2.66 | 11.15 | Upgrade
|
| Pretax Income | 34.62 | -12.16 | -25.55 | 94.83 | 92.65 | -5.53 | Upgrade
|
| Income Tax Expense | 6.09 | 2.01 | -7.67 | 28.01 | 28.44 | 0.85 | Upgrade
|
| Earnings From Continuing Operations | 28.53 | -14.17 | -17.89 | 66.82 | 64.21 | -6.38 | Upgrade
|
| Net Income | 28.53 | -14.17 | -17.89 | 66.82 | 64.21 | -6.38 | Upgrade
|
| Net Income to Common | 28.53 | -14.17 | -17.89 | 66.82 | 64.21 | -6.38 | Upgrade
|
| Net Income Growth | - | - | - | 4.07% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| EPS (Basic) | 2.78 | -1.38 | -1.74 | 6.52 | 6.26 | -0.62 | Upgrade
|
| EPS (Diluted) | 2.78 | -1.38 | -1.74 | 6.52 | 6.26 | -0.62 | Upgrade
|
| EPS Growth | - | - | - | 4.07% | - | - | Upgrade
|
| Free Cash Flow | - | 20.89 | -258.62 | 32.67 | 134.73 | 101.44 | Upgrade
|
| Free Cash Flow Per Share | - | 2.04 | -25.22 | 3.19 | 13.14 | 9.89 | Upgrade
|
| Gross Margin | 59.66% | 54.56% | 46.08% | 54.60% | 56.17% | 50.07% | Upgrade
|
| Operating Margin | 10.02% | 6.70% | -2.02% | 8.30% | 9.65% | 2.19% | Upgrade
|
| Profit Margin | 3.20% | -1.70% | -1.98% | 6.05% | 5.39% | -0.70% | Upgrade
|
| Free Cash Flow Margin | - | 2.50% | -28.67% | 2.96% | 11.31% | 11.19% | Upgrade
|
| EBITDA | 157.74 | 119.25 | 38.44 | 155.1 | 175.38 | 79 | Upgrade
|
| EBITDA Margin | 17.68% | 14.29% | 4.26% | 14.04% | 14.72% | 8.72% | Upgrade
|
| D&A For EBITDA | 68.38 | 63.37 | 56.7 | 63.36 | 60.39 | 59.18 | Upgrade
|
| EBIT | 89.36 | 55.88 | -18.25 | 91.74 | 114.99 | 19.82 | Upgrade
|
| EBIT Margin | 10.02% | 6.70% | -2.02% | 8.30% | 9.65% | 2.19% | Upgrade
|
| Effective Tax Rate | 17.59% | - | - | 29.54% | 30.70% | - | Upgrade
|
| Revenue as Reported | 914.68 | 847.6 | 954.12 | 1,150 | 1,208 | 961.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.